Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/aje/kwab263

PubMed Identifier: 34753177

Publication URI: http://europepmc.org/abstract/MED/34753177

Type: Journal Article/Review

Volume: 191

Parent Publication: American journal of epidemiology

Issue: 3

ISSN: 0002-9262